Peripheral neuropathy in severe COVID‐19 resolved with therapeutic plasma exchange

Peripheral neuropathies including Guillain‐Barré syndrome may be linked to life‐threatening COVID‐19. Plasma exchange is a safe rescue therapy in severe COVID‐19 with associated neurological manifestations and thromboinflammation.

Detalles Bibliográficos
Autores principales: Faqihi, Fahad, Alharthy, Abdulrahman, Memish, Ziad A., Kutsogiannis, Demetrios J., Brindley, Peter G., Karakitsos, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675564/
https://www.ncbi.nlm.nih.gov/pubmed/33230414
http://dx.doi.org/10.1002/ccr3.3397
_version_ 1783611675337818112
author Faqihi, Fahad
Alharthy, Abdulrahman
Memish, Ziad A.
Kutsogiannis, Demetrios J.
Brindley, Peter G.
Karakitsos, Dimitrios
author_facet Faqihi, Fahad
Alharthy, Abdulrahman
Memish, Ziad A.
Kutsogiannis, Demetrios J.
Brindley, Peter G.
Karakitsos, Dimitrios
author_sort Faqihi, Fahad
collection PubMed
description Peripheral neuropathies including Guillain‐Barré syndrome may be linked to life‐threatening COVID‐19. Plasma exchange is a safe rescue therapy in severe COVID‐19 with associated neurological manifestations and thromboinflammation.
format Online
Article
Text
id pubmed-7675564
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-76755642020-11-19 Peripheral neuropathy in severe COVID‐19 resolved with therapeutic plasma exchange Faqihi, Fahad Alharthy, Abdulrahman Memish, Ziad A. Kutsogiannis, Demetrios J. Brindley, Peter G. Karakitsos, Dimitrios Clin Case Rep Case Reports Peripheral neuropathies including Guillain‐Barré syndrome may be linked to life‐threatening COVID‐19. Plasma exchange is a safe rescue therapy in severe COVID‐19 with associated neurological manifestations and thromboinflammation. John Wiley and Sons Inc. 2020-10-07 /pmc/articles/PMC7675564/ /pubmed/33230414 http://dx.doi.org/10.1002/ccr3.3397 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Faqihi, Fahad
Alharthy, Abdulrahman
Memish, Ziad A.
Kutsogiannis, Demetrios J.
Brindley, Peter G.
Karakitsos, Dimitrios
Peripheral neuropathy in severe COVID‐19 resolved with therapeutic plasma exchange
title Peripheral neuropathy in severe COVID‐19 resolved with therapeutic plasma exchange
title_full Peripheral neuropathy in severe COVID‐19 resolved with therapeutic plasma exchange
title_fullStr Peripheral neuropathy in severe COVID‐19 resolved with therapeutic plasma exchange
title_full_unstemmed Peripheral neuropathy in severe COVID‐19 resolved with therapeutic plasma exchange
title_short Peripheral neuropathy in severe COVID‐19 resolved with therapeutic plasma exchange
title_sort peripheral neuropathy in severe covid‐19 resolved with therapeutic plasma exchange
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675564/
https://www.ncbi.nlm.nih.gov/pubmed/33230414
http://dx.doi.org/10.1002/ccr3.3397
work_keys_str_mv AT faqihifahad peripheralneuropathyinseverecovid19resolvedwiththerapeuticplasmaexchange
AT alharthyabdulrahman peripheralneuropathyinseverecovid19resolvedwiththerapeuticplasmaexchange
AT memishziada peripheralneuropathyinseverecovid19resolvedwiththerapeuticplasmaexchange
AT kutsogiannisdemetriosj peripheralneuropathyinseverecovid19resolvedwiththerapeuticplasmaexchange
AT brindleypeterg peripheralneuropathyinseverecovid19resolvedwiththerapeuticplasmaexchange
AT karakitsosdimitrios peripheralneuropathyinseverecovid19resolvedwiththerapeuticplasmaexchange

Ejemplares similares